UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052364
Receipt number R000059618
Scientific Title Effectiveness of Cardiac Rehabilitation for Secondary Prevention of Myocardial Infarction : Investigation using coronary CT and cardiopulmonary stress test
Date of disclosure of the study information 2023/10/01
Last modified on 2023/10/01 11:03:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of Cardiac Rehabilitation for Secondary Prevention of Myocardial Infarction

Acronym

Cardiac Rehabilitation for Secondary Prevention of Myocardial Infarction

Scientific Title

Effectiveness of Cardiac Rehabilitation for Secondary Prevention of Myocardial Infarction : Investigation using coronary CT and cardiopulmonary stress test

Scientific Title:Acronym

Cardiac Rehabilitation for Secondary Prevention of Myocardial Infarction

Region

Japan


Condition

Condition

Acute Coronary Syndrome

Classification by specialty

Cardiology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine whether cardiac rehabilitation is useful in preventing recurrence (secondary prevention) in patients with acute coronary syndromes (acute myocardial infarction and unstable angina) by evaluating the presence of plaque extension on coronary CT over time.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Plaque extension on coronary CT one year after the onset of acute coronary syndrome compared to immediately after the onset of acute coronary syndrome.

Key secondary outcomes

Cardiovascular events: all-cause mortality, cardiac death, acute coronary syndrome, angina requiring hospitalization, heart failure requiring hospitalization
CT findings: changes in non-calcified plaque volume and pericardial fat in plaque quantitative evaluation
Rehabilitation indices: change in cardiac anaerobic metabolic threshold (AT), maximal oxygen uptake (peak VO2), and muscle mass


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients admitted to Fujita Health University Hospital with acute coronary syndromes who underwent PCI or who were judged not to require invasive treatment.
Patients who have given their free and voluntary written consent to participate in this study after receiving full explanation and with full understanding.
Patients 20 years of age or older at the time consent is obtained

Key exclusion criteria

1. Cases of acute coronary syndrome in which the lesion responsible for this acute coronary syndrome did not undergo the necessary revascularization procedures and remained as an obstructive lesion.
2. Cases after coronary artery bypass grafting
3. Cases in which CT imaging is not possible due to allergy to contrast agent
4. Cases with estimated glomerular filtration rate (eGFR) <30
5. Cases with pregnant or lactating women
6. Patients deemed by the attending physician to be unsuitable for participation in the study (including issues with imaging conditions)
7. Patients deemed inappropriate by the Principal Investigator or Principal Investigator for other reasons

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Hideki
Middle name
Last name Kawai

Organization

Fujita Health University

Division name

Department of Cardiology

Zip code

470-1192

Address

1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi

TEL

0562-93-2312

Email

hkawai@fujita-hu.ac.jp


Public contact

Name of contact person

1st name Hideki
Middle name
Last name Kawai

Organization

Fujita Health University

Division name

Department of Cardiology

Zip code

470-1192

Address

1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi

TEL

0562-93-2312

Homepage URL


Email

hkawai@fujita-hu.ac.jp


Sponsor or person

Institute

Fujita Health University

Institute

Department

Personal name



Funding Source

Organization

MEXT: Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fujita Medical University Medical Research Ethics Review Committee

Address

1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi

Tel

0562-93-2865

Email

f-irb@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 05 Month 31 Day

Date of IRB

2023 Year 05 Month 31 Day

Anticipated trial start date

2023 Year 05 Month 31 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Within 1 month after admission: blood tests, cardiopulmonary exercise testing, coronary CT
One year after the first CT: blood test, cardiopulmonary exercise testing, coronary CT


Management information

Registered date

2023 Year 10 Month 01 Day

Last modified on

2023 Year 10 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059618